Prosecution Insights
Prosecution Insights
53 pending office actions • 25 clients • 50 examiners • 33 art units • 0 of 53 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 27 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 27 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 6 (11%) |
| §103 only | 14 (26%) |
| §102 only | 1 (2%) |
| §112 only | 3 (6%) |
| Double-patenting + other | 5 (9%) |
| Multi-statute (no §101) | 24 (45%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OLSON, ANDREA STEFFEL | 2 | 62.2% | -11.9% |
| PIHONAK, SARAH | 2 | 61.1% | +42.9% |
| PAK, JOHN D | 2 | 52.2% | +37.6% |
| PRINCE JR, FREDDIE GARY | 1 | 78.9% | +20.7% |
| ORKIN, ALEXANDER J | 1 | 65.5% | +26.9% |
| DONOHUE, SEAN R | 1 | 41.5% | +21.3% |
| SHEN, YANXIN NMN | 1 | 83.3% | +27.8% |
| SHIAO, REI TSANG | 1 | 79.9% | -33.9% |
| ONDACHI, PAULINE WANJIKU MUCH | 1 | — | — |
| MCDOWELL, BRIAN E | 1 | 74.2% | +30.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18110292 | METHOD FOR PREPARING ACTIVATED CARBON | MENON, KRISHNAN S | 191d overdue |
| 18634406 | SYNTHETIC GENOMIC SAFE HARBORS AND METHODS THEREOF | SULLIVAN, STEPHANIE LAUREN | 131d overdue |
| 18034603 | DESIGN METHODS AND MOTION CONTROL ALGORITHMS FOR IMPACT-RESILIENT MOBILE ROBOTS | MUELLER, SARAH ALEXANDRA | 53d overdue |
| 17928535 | METHOD FOR PROVIDING CORROSION PROTECTION TO A PRESSURIZED WATER-STEAM SYSTEM | DIAZ, MATTHEW R | 51d overdue |
| 18071353 | THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B | WHITEMAN, BRIAN A | 43d overdue |
| 18279380 | METHODS OF ENHANCING ANTIBODY THERAPIES | ALSOMAIRY, SARAH ABDOALATIF | 23d overdue |
| 17296506 | METHODS FOR TREATING DYSREGULATED LIPID METABOLISM | AEDER, SEAN E | 15d overdue |
| 18247616 | A DNA Assembly Mix And Method Of Uses Thereof | TSAY, MARSHA M | 9d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18639608 | THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF | MCDOWELL, BRIAN E | 3d overdue |
| 18278904 | COMPOUNDS AND METHODS FOR TREATING CONGENITAL ERYTHROPOIETIC PORPHYRIA | PIHONAK, SARAH | 22d |
| 18237360 | METALLOENZYME MODULATORS | PIHONAK, SARAH | 27d |
| 18024034 | DITHIOPHOSPHATE DERIVATIVES AS HYDROGEN SULFIDE RELEASE CHEMICALS FOR IMPROVING PLANT GROWTH AND CROP YIELD | PAK, JOHN D | 53d |
| 18868551 | Untitled | PRINCE JR, FREDDIE GARY | — |
| 19184578 | PULMONARY ARTERY FLOW RESTRICTOR | ORKIN, ALEXANDER J | — |
| 18896069 | COMPOSITIONS FOR CHELATING METALS AT LOW TEMPERATURES | DONOHUE, SEAN R | — |
| 18724911 | METHODS FOR IMPROVING PROTEIN DELIVERY TO PLANT CELLS BY BIOLISTICS | SHEN, YANXIN NMN | — |
| Art Unit | Apps |
|---|---|
| 1693 | 5 |
| 1624 | 3 |
| 1699 | 3 |
| 1663 | 2 |
| 1635 | 2 |
| 1658 | 2 |
| 1627 | 2 |
| 1642 | 2 |
| 1759 | 2 |
| 1636 | 2 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18868551 | Untitled | The Regents of the University of California | PRINCE JR, FREDDIE GARY | §101§103§112Other | Non-Final OA | — | Pending | ||
| 19184578 | PULMONARY ARTERY FLOW RESTRICTOR | Regents Of The University Of Minnesota | ORKIN, ALEXANDER J | §103 | Non-Final OA | — | Pending | Apr 21, 2025 | |
| 18896069 | COMPOSITIONS FOR CHELATING METALS AT LOW TEMPERATURES | UNIVERSITY OF IOWA RESEARCH FOUNDATION | DONOHUE, SEAN R | 1618 | §102§103§112DP | Non-Final OA | — | Pending | Sep 25, 2024 |
| 18883520 | TARGETED COMPOSITIONS | Arbutus Biopharma Corporation | OLSON, ANDREA STEFFEL | 1693 | §103 | Final Rejection | 60d overdue | Pending | Sep 12, 2024 |
| 18724911 | METHODS FOR IMPROVING PROTEIN DELIVERY TO PLANT CELLS BY BIOLISTICS | The Regents of the University of California | SHEN, YANXIN NMN | 1663 | §103§112 | Non-Final OA | — | Pending | Jun 27, 2024 |
| 18662929 | NHE3-BINDING COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT | Ardelyx, Inc. | SHIAO, REI TSANG | §112DP | Non-Final OA | — | Pending | May 13, 2024 | |
| 18705175 | TOLL-LIKE RECEPTOR AGONISTS AND ANTAGONISTS AND USES THEREOF | Regents Of The University Of Minnesota | ONDACHI, PAULINE WANJIKU MUCH | §103DP | Non-Final OA | — | Pending | Apr 26, 2024 | |
| 18639608 | THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF | Regents Of The University Of Minnesota | MCDOWELL, BRIAN E | 1624 | §102§103 | Non-Final OA | 3d overdue | Pending | Apr 18, 2024 |
| 18633908 | THERAPEUTIC COMPOUNDS | Regents Of The University Of Minnesota | MILLER, DALE R | §103 | Non-Final OA | — | Pending | Apr 12, 2024 | |
| 18634406 | SYNTHETIC GENOMIC SAFE HARBORS AND METHODS THEREOF | The Regents of the University of California | SULLIVAN, STEPHANIE LAUREN | 1635 | §102§103 | Final Rejection | 131d overdue | Pending | Apr 12, 2024 |
| 18700140 | IMPROVED CEREBRAL ANGIOGRAPHY CATHETER | Rutgers, The State University Of New Jersey | FERNANDEZ, KATHERINE L | 3798 | §103 | Non-Final OA | — | Pending | Apr 10, 2024 |
| 18613381 | USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS | Lexicon Pharmaceuticals, Inc. | CRAIGO, BAHAR ALAWI | 1699 | §101§102§112 | Non-Final OA | — | Pending | Mar 22, 2024 |
| 18409330 | TARGETED NUCLEIC ACID CONJUGATE COMPOSITIONS | Arbutus Biopharma Corporation | OLSON, ANDREA STEFFEL | 1693 | DPOther | Final Rejection | — | Pending | Jan 10, 2024 |
| 18572411 | THERAPEUTIC COMPOUNDS | Taxis Pharmaceuticals, Inc. | CHENG, KAREN | 1623 | §102§103§112 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18517049 | PHARMACOLOGICAL DEPLETION OF HEME FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME | The Scripps Research Institute | NEAGU, IRINA | 1629 | §102§103 | Non-Final OA | — | Pending | Nov 22, 2023 |
| 18286955 | Glycan Targets of Serum IgG and IgM Antibodies | Regents Of The University Of Minnesota | WEN, SHARON X | 1641 | §103 | Non-Final OA | — | Pending | Oct 13, 2023 |
| 18284786 | EZRIN PEPTIDE 1 FOR USE IN A METHOD OF TREATING POST COVID-19 | Pantapharm AG | BANERJEE, KOYELI | 1658 | §112DP | Final Rejection | — | Pending | Sep 28, 2023 |
| 18372535 | CATALYSTS | The Regents of the University of California | SPIES, BRADLEY R | 1742 | §103 | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18244728 | SPIRALED PLASTIC PANCREATICOBILIARY STENT AND DEPLOYMENT SYSTEM | Regents Of The University Of Minnesota | NGUYEN, VI X | 3771 | §103 | Final Rejection | — | Pending | Sep 11, 2023 |
| 18279380 | METHODS OF ENHANCING ANTIBODY THERAPIES | UNIVERSITY OF IOWA RESEARCH FOUNDATION | ALSOMAIRY, SARAH ABDOALATIF | 1646 | §103§112 | Non-Final OA | 23d overdue | Pending | Aug 29, 2023 |
| 18278904 | COMPOUNDS AND METHODS FOR TREATING CONGENITAL ERYTHROPOIETIC PORPHYRIA | Regents of the University of Michigan | PIHONAK, SARAH | 1627 | §102§103 | Non-Final OA | 22d | Pending | Aug 25, 2023 |
| 18237360 | METALLOENZYME MODULATORS | Regents Of The University Of Minnesota | PIHONAK, SARAH | 1627 | §102§112 | Non-Final OA | 27d | Pending | Aug 23, 2023 |
| 18277444 | ARTIFICIAL DNA REPLISOME AND METHODS OF USE THEREOF | Regents Of The University Of Minnesota | FRONDA, CHRISTIAN L | 1652 | §103§112 | Non-Final OA | 70d | Pending | Aug 16, 2023 |
| 18546217 | SMALL MOLECULE ACTIVATORS OF YAP TRANSCRIPTIONAL ACTIVITY FOR REGENERATIVE ORGAN REPAIR | The Scripps Research Institute | BRAUN, MADELINE E | 1624 | §103§112 | Non-Final OA | — | Pending | Aug 11, 2023 |
| 18276823 | ANTI-TRANSFERRIN RECEPTOR FUSION PROTEINS AND METHODS OF USE THEREOF | Denali Therapeutics Inc. | LU, CHENG | 1642 | §102§103§112Other | Non-Final OA | 46d | Pending | Aug 10, 2023 |
| 18276424 | BACTERIOPHAGE LYSINE, CHIMERA THEREOF AND APPLICATION THEREOF | Wuhan Lysigen Bio-Tech Company Limited | BOWERS, ERIN M | 1653 | §112 | Non-Final OA | — | Pending | Aug 08, 2023 |
| 18228422 | SELECTIVE BRD4-DEGRADER MOLECULES | Regents Of The University Of Minnesota | BURKETT, DANIEL JOHN | 1624 | §112 | Final Rejection | — | Pending | Jul 31, 2023 |
| 18274907 | A PROCESS FOR PREPARING A VEGAN EDIBLE PRODUCT FROM EDIBLE NON-ANIMAL PROTEINS | BK Giulini GmbH | BEKKER, KELLY JO | 1792 | §103§112 | Final Rejection | 84d | Pending | Jul 28, 2023 |
| 18274863 | A PROCESS FOR PREPARING A VEGAN EDIBLE PRODUCT FROM EDIBLE NON-ANIMAL PROTEINS | BK Giulini GmbH | GWARTNEY, ELIZABETH A | 1759 | §103 | Final Rejection | 35d overdue | Pending | Jul 28, 2023 |
| 18215463 | MATERIALS AND METHODS FOR WATER PURIFICATION | UNIVERSITY OF NOTRE DAME DU LAC | BASS, DIRK R | 1779 | §102 | Final Rejection | — | Pending | Jun 28, 2023 |
| 18038910 | ANTI-PD-L1 IMMUNOCONJUGATES, AND USES THEREOF | BOLT BIOTHERAPEUTICS, INC. | ESSEX, LAURA ANN | 1675 | §102§103§112 | Non-Final OA | — | Pending | May 25, 2023 |
| 18034603 | DESIGN METHODS AND MOTION CONTROL ALGORITHMS FOR IMPACT-RESILIENT MOBILE ROBOTS | The Regents of the University of California | MUELLER, SARAH ALEXANDRA | 3669 | §103§112 | Non-Final OA | 53d overdue | Pending | Apr 28, 2023 |
| 18139768 | POLYURETHANES AND METHODS TO PREPARE POLYURETHANES | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | MCCULLEY, MEGAN CASSANDRA | 1767 | §103 | Final Rejection | — | Pending | Apr 26, 2023 |
| 18032768 | METHODS FOR IMPROVING PLANT GROWTH AND CROP YIELD BY USING COMPOUNDS OF TRISULPHIDE OR TETRASULPHIDE | UNIVERSITY OF IOWA RESEARCH FOUNDATION | PAK, JOHN D | 1699 | §102§103§112 | Non-Final OA | — | Pending | Apr 19, 2023 |
| 18247616 | A DNA Assembly Mix And Method Of Uses Thereof | National University Of Singapore | TSAY, MARSHA M | 1656 | §101§102§103§112 | Non-Final OA | 9d overdue | Pending | Mar 31, 2023 |
| 18024034 | DITHIOPHOSPHATE DERIVATIVES AS HYDROGEN SULFIDE RELEASE CHEMICALS FOR IMPROVING PLANT GROWTH AND CROP YIELD | UNIVERSITY OF IOWA RESEARCH FOUNDATION | PAK, JOHN D | 1699 | §102§103Other | Non-Final OA | 53d | Pending | Feb 28, 2023 |
| 18110292 | METHOD FOR PREPARING ACTIVATED CARBON | The Regents of the University of California | MENON, KRISHNAN S | 1777 | §102§103 | Final Rejection | 191d overdue | Pending | Feb 15, 2023 |
| 18010108 | BIOMARKER COMBINATIONS FOR DETERMINING AGGRESSIVE PROSTATE CANCER | Minomic International Ltd. | POHNERT, STEVEN C | 1683 | §101§103§112DPOther | Non-Final OA | 77d | Pending | Dec 13, 2022 |
| 18008391 | IDENTIFICATION OF LOW-DENSITY INFLAMMATORY NEUTROPHILS IN SEVERE COVID-19 PATIENTS | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. | WANG, RUIXUE | 1672 | §101§102§112 | Non-Final OA | 20d | Pending | Dec 05, 2022 |
| 17928535 | METHOD FOR PROVIDING CORROSION PROTECTION TO A PRESSURIZED WATER-STEAM SYSTEM | Kurita Water Industries Ltd. | DIAZ, MATTHEW R | 1761 | §103§112 | Final Rejection | 51d overdue | Pending | Nov 29, 2022 |
| 18071353 | THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B | Arbutus Biopharma Corporation | WHITEMAN, BRIAN A | 1636 | §102§112 | Final Rejection | 43d overdue | Pending | Nov 29, 2022 |
| 18070288 | CHLOROPLAST TARGETING PEPTIDES AND CONJUGATES AND COMPOSITIONS THEREOF | The Regents of the University of California | SPEED, DEQUANTARIUS JAVON | 1663 | §103 | Non-Final OA | 15d | Pending | Nov 28, 2022 |
| 17923171 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF SARS-COV-2 | The Scripps Research Institute | SCHACHERMEYER, SAMANTHA LYNN | 1693 | §102§103 | Non-Final OA | 65d | Pending | Nov 03, 2022 |
| 17918448 | GUANIDINE-MODIFIED C-TERMINUS VANCOMYCIN COMPOUNDS, COMPOSITIONS AND METHODS | The Scripps Research Institute | REYNOLDS, FRED H | 1658 | §103Other | Non-Final OA | 30d overdue | Pending | Oct 12, 2022 |
| 17916539 | NOVEL TUMOR-SPECIFIC ANTIGENS FOR ACUTE MYELOID LEUKEMIA (AML) AND USES THEREOF | UNIVERSITE DE MONTREAL | VAN DRUFF, SYDNEY | 1643 | §102§103 | Final Rejection | — | Pending | Sep 30, 2022 |
| 17915559 | SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ | The Scripps Research Institute | STOCKTON, LAURA LYNNE | 1626 | §102§112 | Non-Final OA | — | Pending | Sep 29, 2022 |
| 17794527 | CITRUS HUANGLONGBING THERAPEUTIC COMPOUNDS | Point Loma Nazarene University | ARMSTRONG, SUSANNAH SIPPLE | 1616 | §101§102§112 | Non-Final OA | 27d | Pending | Jul 21, 2022 |
| 17787089 | SYNTHETIC PROCESSES AND INTERMEDIATES | Arbutus Biopharma Corporation | VANHORN, ABIGAIL LOUISE | 1636 | §103 | Non-Final OA | 21d | Pending | Jun 17, 2022 |
| 17784879 | ABS RUBBER POWDER WITH LOW IMPURITY CONTENT, PREPARATION METHOD THEREFOR, AND ABS RESIN | Wanhua Chemical Group Co., Ltd. | BLAND, ALICIA | 1759 | §103 | Final Rejection | 19d | Pending | Jun 13, 2022 |
| 17631209 | PROCESS FOR PREPARING THE CRYSTALLINE FORM II OF SOTAGLIFLOZIN | Lexicon Pharmaceuticals, Inc. | BERRY, LAYLA D | 1693 | §112Other | Non-Final OA | 53d | Pending | Jan 28, 2022 |
| 17625020 | POTENTIATION OF ANTIVIRAL NUCLEOBASES AS RNA VIRUS THERAPY | Regents Of The University Of Minnesota | LEE, HOI YAN NMN | 1693 | §103 | Non-Final OA | 23d overdue | Pending | Jan 05, 2022 |
| 17426338 | MEANS AND METHODS FOR PREPARING ENGINEERED TARGET PROTEINS BY GENETIC CODE EXPANSION IN A TARGET PROTEIN-SELECTIVE MANNER | European Molecular Biology Laboratory | MEYERING, SHABANA SHABBEER | 1635 | §102§103§112 | Non-Final OA | — | Pending | Jul 28, 2021 |
| 17296506 | METHODS FOR TREATING DYSREGULATED LIPID METABOLISM | Denali Therapeutics Inc. | AEDER, SEAN E | 1642 | §103§112 | Non-Final OA | 15d overdue | Pending | May 24, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial